I agree that this site is using cookies. You can find further informations here.
X
Ruigrok, Eline A. M
~ 300  results:
Search for persons X
?
1

GRPR versus PSMA: expression profiles during prostate cance..:

Verhoeven, Marjolein ; Ruigrok, Eline A. M. ; van Leenders, Geert J. L. H....
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

Safety of [177Lu]Lu-NeoB treatment: a preclinical study cha..:

Ruigrok, Eline A. M. ; Verhoeven, Marjolein ; Konijnenberg, Mark W....
European Journal of Nuclear Medicine and Molecular Imaging.  49 (2022)  13 - p. 4440-4451 , 2022
Link: https://doi.org/10.1007/..
 
?
3

In vitro dose effect relationships of actinium-225- and lut..:

Ruigrok, Eline A. M. ; Tamborino, Giulia ; de Blois, Erik...
European Journal of Nuclear Medicine and Molecular Imaging.  49 (2022)  11 - p. 3627-3638 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Correction to: In vitro dose effect relationships of actini..:

Ruigrok, Eline A. M. ; Tamborino, Giulia ; de Blois, Erik...
European Journal of Nuclear Medicine and Molecular Imaging.  49 (2022)  11 - p. 3956-3957 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radio..:

Tamborino, Giulia ; De Saint-Hubert, Marijke ; Struelens, Lara...
EJNMMI Physics.  7 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
6

Extensive preclinical evaluation of lutetium-177-labeled PS..:

Ruigrok, Eline A. M. ; van Vliet, Nicole ; Dalm, Simone U....
European Journal of Nuclear Medicine and Molecular Imaging.  48 (2020)  5 - p. 1339-1350 , 2020
Link: https://doi.org/10.1007/..
 
?
7

The Future of PSMA-Targeted Radionuclide Therapy: An Overvi..:

Ruigrok, Eline A.M. ; van Weerden, Wytske M. ; Nonnekens, Julie.
Pharmaceutics.  11 (2019)  11 - p. 560 , 2019
Link: https://doi.org/10.3390/..
 
?
8

Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radio..:

Tamborino, G. (Giulia) ; De Saint-Hubert, M. (Marijke) ; Struelens, L. (Lara)...
http://repub.eur.nl/pub/124904.  , 2020
Link: http://repub.eur.nl/pub/..
 
?
9

The future of PSMA-targeted radionuclide therapy: An overvi..:

Ruigrok, E.A.M. (Eline A. M.) ; Weerden, W.M. (Wytske) van ; Nonnekens, J. (Julie).
http://repub.eur.nl/pub/120935.  , 2019
Link: http://repub.eur.nl/pub/..
 
?
10

Cationic amphiphilic drugs as potential anticancer therapy ..:

van der Horst, Geertje ; van de Merbel, Arjanneke F. ; Ruigrok, Eline...
Molecular Oncology.  14 (2020)  12 - p. 3121-3134 , 2020
Link: https://doi.org/10.1002/..
 
?
11

In vitro dose effect relationships of actinium-225- and lut..:

Ruigrok, Eline A. M ; Tamborino, Giulia ; de Blois, Erik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399067/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Preclinical Assessment of the Combination of PSMA-Targeting..:

Ruigrok, Eline A. M ; Verkaik, Nicole S ; de Blois, Erik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316488/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

In vitro dose effect relationships of actinium-225- and lut..:

Ruigrok, Eline A.M ; Tamborino, Giulia ; de Blois, Erik...
Ruigrok , E A M , Tamborino , G , de Blois , E , Roobol , S J , Verkaik , N , De Saint-Hubert , M , Konijnenberg , M W , van Weerden , W M , de Jong , M & Nonnekens , J 2022 , ' In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I &T ' , European Journal of Nuclear Medicine and Molecular Imaging . https://doi.org/10.1007/s00259-022-05821-w.  , 2022
Link: https://pure.eur.nl/en/p..
 
?
14

Safety of [(177)Lu]Lu-NeoB treatment: a preclinical study c..:

Ruigrok, Eline A. M ; Verhoeven, Marjolein ; Konijnenberg, Mark W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605926/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Correction to: In vitro dose effect relationships of actini..:

Ruigrok, Eline A. M ; Tamborino, Giulia ; de Blois, Erik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399007/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15